Total Payments
$826.90
2024 Payments
$73.83
Companies
10
Transactions
52
Medicare Patients
1,856
Medicare Billing
$450,054
Payment Breakdown by Category
Food & Beverage$826.90 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $826.90 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $275.47 | 18 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $133.68 | 9 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $116.22 | 8 | $0 (2020) |
| ABBVIE INC. | $94.72 | 5 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $53.72 | 2 | $0 (2022) |
| PFIZER INC. | $53.20 | 4 | $0 (2021) |
| Gilead Sciences, Inc. | $48.68 | 3 | $0 (2021) |
| UCB, Inc. | $22.98 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $16.12 | 1 | $0 (2017) |
| Allergan Inc. | $12.11 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73.83 | 4 | ABBVIE INC. ($73.83) |
| 2023 | $20.89 | 1 | ABBVIE INC. ($20.89) |
| 2022 | $168.57 | 10 | Janssen Pharmaceuticals, Inc ($90.03) |
| 2021 | $298.63 | 19 | Janssen Pharmaceuticals, Inc ($121.94) |
| 2020 | $81.64 | 5 | Janssen Pharmaceuticals, Inc ($63.50) |
| 2019 | $54.71 | 4 | Merck Sharp & Dohme Corporation ($31.47) |
| 2018 | $37.71 | 3 | Merck Sharp & Dohme Corporation ($26.57) |
| 2017 | $90.92 | 6 | Merck Sharp & Dohme Corporation ($40.04) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/21/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/13/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/03/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/29/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/13/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/31/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/28/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/05/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/04/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/20/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $39.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/04/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.00 | General |
| 10/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/09/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.36 | General |
| 09/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/23/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 410 | 727 | $123,945 | $73,266 |
| 2022 | 5 | 281 | 640 | $107,059 | $83,132 |
| 2021 | 9 | 489 | 936 | $164,945 | $124,372 |
| 2020 | 9 | 676 | 1,335 | $218,957 | $169,286 |
Total Patients
1,856
Total Services
3,638
Medicare Billing
$450,054
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 56 | 163 | $36,020 | $26,872 | 74.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 107 | 226 | $33,163 | $20,446 | 61.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 181 | $25,882 | $10,872 | 42.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 102 | 109 | $20,570 | $9,547 | 46.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 36 | $7,121 | $4,787 | 67.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $1,190 | $742.03 | 62.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 86 | 346 | $75,452 | $59,132 | 78.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 86 | 167 | $17,018 | $12,946 | 76.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $6,119 | $4,379 | 71.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 47 | 49 | $5,138 | $4,050 | 78.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 47 | $3,332 | $2,624 | 78.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 119 | 467 | $106,915 | $81,012 | 75.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 102 | 182 | $19,938 | $14,707 | 73.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 83 | 84 | $17,315 | $12,938 | 74.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 72 | 72 | $8,010 | $6,008 | 75.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 74 | $5,415 | $4,222 | 78.0% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 14 | 14 | $2,555 | $1,990 | 77.9% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 14 | 14 | $1,902 | $1,356 | 71.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $1,663 | $1,163 | 69.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 17 | 17 | $1,232 | $976.14 | 79.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 146 | 552 | $126,498 | $98,446 | 77.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 152 | 329 | $35,128 | $27,373 | 77.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 97 | 103 | $22,257 | $16,205 | 72.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 104 | 107 | $11,679 | $9,185 | 78.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 81 | 146 | $10,757 | $8,480 | 78.8% |
About Dr. Ryan O'connell, D.O
Dr. Ryan O'connell, D.O is a Internal Medicine healthcare provider based in Danville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1083973374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan O'connell, D.O has received a total of $826.90 in payments from pharmaceutical and medical device companies, with $73.83 received in 2024. These payments were reported across 52 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($826.90).
As a Medicare-enrolled provider, O'connell has provided services to 1,856 Medicare beneficiaries, totaling 3,638 services with total Medicare billing of $450,054. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Danville, VA
- Active Since 05/08/2012
- Last Updated 12/05/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083973374
Products in Payments
- XARELTO (Drug) $275.47
- ENTRESTO (Drug) $133.68
- DIFICID (Drug) $63.04
- ELIQUIS (Drug) $57.54
- LifeVest (Device) $53.72
- AVYCAZ (Drug) $48.35
- DALVANCE (Drug) $41.87
- NOXAFIL (Drug) $27.50
- Briviact (Drug) $22.98
- TEFLARO (Drug) $16.61
- ZERBAXA (Drug) $13.71
- CHANTIX (Drug) $11.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Danville
Dr. Christopher Still, D.o, D.O
Internal Medicine — Payments: $461,951
Internal Medicine $461,951
Dr. Brendan Carry, M.d, M.D
Internal Medicine — Payments: $209,824
Internal Medicine $209,824
Prince Anand, M.d, M.D
Internal Medicine — Payments: $188,555
Internal Medicine $188,555
Jessica Mckee, D.o, D.O
Internal Medicine — Payments: $57,390
Internal Medicine $57,390
Michael Caplan, Md, MD
Internal Medicine — Payments: $41,374
Internal Medicine $41,374
Dr. Mark Reginato, M.d, M.D
Internal Medicine — Payments: $23,997
Internal Medicine $23,997